Genetic predisposition to colorectal cancer: New pieces in the pediatric puzzle

Journal of Pediatric Gastroenterology and Nutrition

Volumn 43, Issue 1, 2006, Pages 5-15

  Durno, Carol A ^a   Gallinger, Steven ^b  

^a HOSPITAL FOR SICK CHILDREN   (Canada)

^b NONE

Author keywords

Familial adenomatous polyposis; Genetic testing; Hereditary nonpolyposis colorectal cancer; MYH mutations; Pediatrics

Indexed keywords

ADENOMATOUS POLYP; AUTOSOMAL DOMINANT DISORDER; AUTOSOMAL RECESSIVE DISORDER; CHILDHOOD; COLORECTAL CANCER; FAMILIAL CANCER; GENE MUTATION; GENETIC PREDISPOSITION; GENETIC SCREENING; HUMAN; MISMATCH REPAIR; MYH GENE; PEDIATRICS; POLYPOSIS; PRIORITY JOURNAL; REVIEW; TUMOR SUPPRESSOR GENE;

ADENOMATOUS POLYPOSIS COLI; ADOLESCENT; BASE PAIR MISMATCH; CHILD; CHILD, PRESCHOOL; COLORECTAL NEOPLASMS; COLORECTAL NEOPLASMS, HEREDITARY NONPOLYPOSIS; DNA GLYCOSYLASES; FIBROMATOSIS, AGGRESSIVE; GENETIC PREDISPOSITION TO DISEASE; GERM-LINE MUTATION; HUMANS; PATIENT COMPLIANCE; PREIMPLANTATION DIAGNOSIS; PRENATAL DIAGNOSIS; RISK FACTORS;

EID: 33745788819     PISSN: 02772116     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.mpg.0000221889.36501.bb     Document Type: Review

References (79)

1. Corredor J, Wambach J, Barnard J. Gastrointestinal polyps in children: advances in molecular genetics, diagnosis, and management. J Pediatr 2001;138:621-8.
2. Hoffenberg EJ, Sauaia A, Maltzman T, et al. Symptomatic colonic polyps in childhood: not so benign. J Pediatr Gastroenterol Nutr 1999;28:175-81.
3. Wijnen JT, Vasen HF, Khan PM, et al. Clinical findings with implications for genetic testing in families with clustering of colorectal cancer. N Engl J Med 1998;339:511-8.
4. Wahlberg SS, Schmeits J, Thomas G, et al. Evaluation of microsatellite instability and immunohistochemistry for the prediction of germ-line MSH2 and MLH1 mutations in hereditary nonpolyposis colon cancer families. Cancer Res 2002;62:3485-92.
5. Durno C, Aronson M, Bapat B, et al. Family history and molecular features of children, adolescents, and young adults with colorectal carcinoma. Gut 2005;54:1146-50.
6. Boland CR, Thibodeau SN, Hamilton SR, et al. A National Cancer Institute workshop on microsatellite instability for cancer detection and familial predisposition: development of international criteria for the determination of microsatellite instability in colorectal cancer. Cancer Res 1998;58:5248-57.
7. Peltomaki P, Vasen HF. Mutations predisposing to hereditary nonpolyposis colorectal cancer: database and results of a collaborative study. The International Collaborative Group on hereditary nonpolyposis colorectal cancer. Gastroenterology 1997;113:1146-58.
8. Truninger K, Menigatti M, Luz J, et al. Immunohistochemical analysis reveals high frequency of PMS2 defects in colorectal cancer. Gastroenterology 2005;128:1160-71.
9. Worthley D, Walsh MD, Berker M, et al. Familial mutations in PMS2 can cause autosomal dominant hereditary nonpolyposis colorectal cancer. Gastroenterology 2005;128:1431-6.
10. Giardiello FM, Brensinger JD, Petersen GM. AGA technical review on hereditary nonpolyposis colorectal cancer and genetic testing. Gastroenterology 2001;121:198-213.
11. Vasen HF, Mecklin JP, Khan PM, et al. The International Collaborative Group on Hereditary Non-Polyposis Colorectal Cancer (ICG-HNPCC). Dis Colon Rectum 1991;34:424-5.
12. Burt RW, Leppert MF, Slattery ML, et al. Genetic testing and phenotype in a large kindred with attenuated familial adenomatous polyposis. Gastroenterology 2004;127:444-51.
13. Peck DA, Watanabe KS, Trueblood HW. Familial polyposis is children. Dis Colon Rectum 1972;15:23-9.
14. Church JM, McGannon E, Burke C. Teenagers with familial adenomatous polyposis: what is their risk for colorectal cancer? Dis Colon Rectum 2002;45:887-9.
15. Debinski HS, Love S, Spigelman AD, et al. Colorectal polyp counts and cancer risk in familial adenomatous polyposis. Gastroenterology 1996;110:1028-30.
16. Wu JS, McGannon EA, Church JM. APC genotype, polyp number, and surgical options in familial adenomatous polyposis. Ann Surg 1998;227:57-62.
17. Bulow S, Bjork J, Christensen IJ, et al. Duodenal adenomatosis in familial adenomatous polyposis. Gut 2004;53:381-6.
18. Heiskanen I, Kellokumpu I, Jarvinen H. Management of duodenal adenomas in 98 patients with familial adenomatous polyposis. Endoscopy 1999;31:412-6.
19. Bjork J, Akerbrant H, Iselius L, et al. Periampullary adenomas and adenocarcinomas in familial adenomatous polyposis: cumulative risks and APC gene mutations. Gastroenterology 2001;121:1127-35.
20. Groves CJ, Saunders BP, Spigelman AD, et al. Duodenal cancer in patients with familial adenomatous polyposis (FAP): results of a 10 year prospective study. Gut 2002;50:636-41.
21. Moozar KL, Madlensky L, Berk T, et al. Slow progression of periampullary neoplasia in familial adenomatous polyposis. J Gastrointest Surg 2002;6:831-7.
22. Hyer W, Beveridge I, Domizio P, et al. Clinical management and genetics of gastrointestinal polyps in children. J Pediatr Gastroenterol Nutr 2000;31:469-79.
23. Attard TM, Cuffari C, Tajouri T, et al. Multicenter experience with upper gastrointestinal polyps in pediatric patients with familial adenomatous polyposis. Am J Gastroenterol 2004;99:681-6.
24. Gurbuz AK, Giardello FM, Petersen GM, et al. Desmoid tumours in familial adenomatous polyposis. Gut 1994;35:377-81.
25. Clark SK, Neale KF, Landgrebe JC, et al. Desmoid tumours complicating familial adenomatous polyposis. Br J Surg 1999;86:1185-9.
26. Bertario L, Russo A, Sala P, et al. Genotype and phenotype factors as determinants of desmoid tumours in patients with familial adenomatous polyposis. Int J Cancer 2001;95:102-7.
27. Soravia C, Berk T, McLeod RS, et al. Desmoid disease in patients with familial adenomatous polyposis. Din Colon Rectum 2000;43:363-9.
28. Caspari R, Olschwang S, Friedl W, et al. Familial adenomatous polyposis: desmoid tumours and lack of ophthalmic lesions (CHRPE) associated with APC mutations beyond codon 1444. Hum Mol Genet 1995;4:337-40.
29. Davies DR, Armstrong JG, Thakker N, et al. Severe Gardner syndrome in families with mutations restricted to a specific region of the APC gene. Am J Hum Genet 1995;57:1151-8.
30. Scott RJ, Froggatt NJ, Trembath RC, et al. Familial infiltrative fibromatosis (desmoid tumours) (MIM135290) caused by a recurrent 3 APC gene mutation. Hum Mol Genet 1996;5:1921-4.
31. Sturt NJH, Gallagher MC, Bassett P, et al. Evidence for genetic predisposition to desmoid tumours in familial adenomatous polyposis independent of the germline APC mutation. Gut 2004;53:1832-6.
32. Nagase H, Miyoshi Y, Horri A, et al. Correlation between the location of germline mutations in the APC gene and the number of colorectal polyps in familial adenomatous polyposis patients. Cancer Res 1992;52:4055-7.
33. van der Luijt RB, Khan PM, Vasen HF, et al. Germline mutations in the 3 part of APC exon 15 do not result in truncated proteins and are associated with attenuated adenomatous polyposis coli. Hum Genet 1996;98:727-34.
34. Soravia C, Berk T, Madlensky L, et al. Genotype-phenotype correlations in attenuated adenomatous polyposis coli. Am J Hum Genet 1998;62:1290-301.
35. Friedl W, Caspari R, Sengteller M, et al. Can APC mutations analysis contribute to therapeutic decisions in familial adenoma-tous polyposis? Experience from 680 FAP families. Gut 2001;48:515-21.
36. Hernegger GS, Moore HG, Guillem JG. Attenuated familial adenomatous polyposis: an evolving and poorly understood entity. Dis Colon Rectum 2002;45:127-36.
37. Leddin D, Hunt R, Champion M, et al. Canadian Association of Gastroenterology and the Canadian Digestive Health Foundation: guidelines on colon cancer screening. Can J Gastroenterol 2004:93-9.
38. Whitelaw S, Northover JM, Hodgson SV. Attitudes to predictive DNA testing in familial adenomatous polyposis. J Med Genet 1996;33:540-3.
39. Bloch M, Hayden M. Opinion: predictive testing for Huntington's disease in childhood: challenges and implications. Am J Hum Genet 1990;46:1-4.
40. Winawer S, Fletcher R, Rex D, et al. American Gastroenterological Association. Colorectal cancer screening and surveillance: clinical guidelines and rationale - update based on new evidence. Gastroenterology 2003;124:544-60.
41. Burt R, Neklason DW. Genetic testing for inherited colon cancer. Gastroenterology 2005;128:1696-716.
42. Giardiello FM, Brensinger JD, Petersen GM, et al. The use and interpretation of commercial APC gene testing for familial adenomatous polyposis. N Engl J Med 1997;336:823-7.
43. Petersen GM, Boyd PA. Gene tests and counseling for colorectal cancer risk: lessons from familial polyposis. Natl Cancer Inst Monogr 1995;17:67-71.
44. Petersen GM, Brensinger JD. Genetic testing and counseling in familial adenomatous polyposis. Oncology 1996;10:89-94.
45. Miller HH, Bauman LJ, Friedman DR, et al. Psychological adjustment of familial polyposis patients and participation in a chemoprevention trial. Int J Psychiatry Med 1986;16:211-30.
46. Burn J, Chapman PD, Eastham EJ. Familial adenomatous polyposis. Arch Dis Child 1994;71:103-5.
47. Dalton A, Shannon NL, Johnson M, et al. Prenatal diagnosis to exclude FAP in a high risk pregnancy. Prenat Diagn 1998;18:751-6.
48. Meissen G, Berchek R. Intended use of predictive testing by those at risk of Huntington's disease. Am J Med Genet 1987;26:283-93.
49. Rechitsky S. Preimplantation genetic diagnosis for cancer predisposition. Reprod Biomed Online 2002;5:148-55.
50. Ao A, Wells D, Handyside AH, et al. Preimplantation genetic diagnosis of inherited cancer: familial adenomatous polyposis coli. J Assist Reprod Genet 1998;15:140-4.
51. Bosch X. UK implements embryo screening for cancer. Lancet 2004;5:704.
52. Al-Tassan N, Chmiel NH, Maynard J, et al. Inherited variants of MYH associated with somatic G:C→T:A mutations in colorectal tumors. Nat Genet 2002;30:227-32.
53. Powell SM, Petersen GM, Krush AJ, et al. Molecular diagnosis of familial adenomatous polyposis. N Engl J Med 1993;329:1982-7.
54. van der Luijt RB, Khan PM, Vasen HF, et al. Molecular analysis of the APC gene in 105 Dutch kindreds with familial adenomatous polyposis: 67 germline mutations identified by DGGE, PTT, and southern analysis. Hum Mutat 1997;9:7-16.
55. Nielsen M, Franken PF, Reinards TH, et al. Multiplicity in polyp count and extracolonic manifestations in 40 Dutch patients with MYH associated polyposis coli (MAP). J Med Genet 2005;42:e54.
56. Sampson JR, Dolwani S, Jones S, et al. Autosomal recessive colorectal adenomatous polyposis due to inherited mutations of MYH. Lancet 2003;362:39-41.
57. Sieber OM, Lipton L, Crabtree M, et al. Multiple colorectal adenomas, classic adenomatous polyposis, and germ-line mutations in MYH. N Engl J Med 2003;348:791-9.
58. Wang L, Baudhuin LM, Boardman LA, et al. MYH mutations in patients with attenuated and classic polyposis and with young-onset colorectal cancer without polyps. Gastroenterology 2004;127:9-16.
59. Venesio T, Molatore S, Cattaneo F, et al. High frequency of MYH gene mutations in a subset of patients with familial adenomatous polyposis. Gastroenterology 2004;126:1681-5.
60. Gismondi V, Meta M, Bonelli L, et al. Prevalence of the Y165C, G382D and 1395delGGA germline mutations of the MYH gene in Italian patients with adenomatous polyposis coli and colorectal adenomas. Int J Cancer 2004;109:680-4.
61. Croitoru ME, Cleary SP, Di Nicola N, et al. Association between biallelic and monoallelic germline MYH gene mutations and colorectal cancer risk. J Natl Cancer Inst 2004;96:1631-4.
62. Bethel CAI, Bhattacharyya N, Hutchinson C, et al. Alimentary tract malignancies in children. J Pediatr Surg 1997;32:1004-9.
63. Vastyan AM, Walker J, Pinter AB, et al. Colorectal carcinoma in children and adolescents - a report of seven cases. Eur J Pediatr Surg 2001;11:338-41.
64. Shankar A, Renaut AJ, Whelan J, et al. Colorectal cancer in adolescents. Ann R Coll Surg Engl 1999;81:100-4.
65. Kam MH, Eu KW, Berben CP, et al. Colorectal cancer in the young: a 12-year review of patients 30 years or less. Colorectal Dis 2004;6:191-4.
66. Bhatia S, Pratt CB, Sharp GB, et al. Family history of cancer in children and young adults with colorectal cancer. Med Pediatr Oncol 1999;33:470-5.
67. Madlensky L, Bapat B, Redston M, et al. Using genetic information to make surgical decisions: report of a case of a 13-year-old boy with colon cancer. Dis Colon Rectum 1997;40:240-3.
68. Hamilton SR, Liu B, Parsons RE, et al. The molecular basis of Turcot's syndrome. N Engl J Med 1995;332:839-47.
69. Huang SC, Lavine JE, Boland PS, et al. Germline characterization of early-aged onset of hereditary non-polyposis colorectal cancer. J Pediatr 2001;138:629-35.
70. Gryfe R, Swallow C, Bapat B, et al. Molecular biology of colorectal cancer. Curr Probl Cancer 1997;21:233-300.
71. Thibodeau SN, French AJ, Roche PC, et al. Altered expression of hMSH2 and hMLH1 in tumors with microsatellite instability and genetic alterations in mismatch repair genes. Cancer Res 1996;56:4836-40.
72. Ricciardone MD, Ozcelik T, Cevher B, et al. Human MLH1 deficiency predisposes to hematological malignancy and neurofibromatosis type 1. Cancer Res 1999;59:290-3.
73. Wang Q, Lasset C, Desseigne F, et al. Neurofibromatosis and early onset of cancers in hMLH1-deficient children. Cancer Res 1999;59:294-7.
74. Whiteside D, McLeod R, Graham G, et al. A homozygous germline mutation in the human MSH2 gene predisposes to hematological malignancy and multiple café-au-lait spots. Cancer Res 2002;62:359-62.
75. Gallinger S, Aronson M, Shayan K, et al. Gastrointestinal cancers and neurofibromatosis type 1 features in children with a germline homozygous MLH1 mutation. Gastroenterology 2004;126:576-85.
76. Jerkic S, Rosewich H, Scharf J-G, et al. Colorectal cancer in two pre-teenage siblings with familial adenomatous polyposis. Eur J Pediatr 2005, online February 2005.
77. Trimbath JD, Petersen GM, Erdman SH, et al. Café-au-lait spots and early onset colorectal neoplasia: a variant of HNPCC? Fam Cancer 2001;1:101-5.
78. Kong S, Amos CI, Luthra R, et al. Effects of cyclin D1 polymorphism on age of onset of hereditary nonpolyposis colorectal cancer. Cancer Res 2000;60:249-52.
79. Gryfe R, Gallinger S. Germline PMS2 mutations: one hit or two? Gastroenterology 2005;128:1506-15.